Peter Svennilson's Net Worth
$192 Million
Estimate Recalculated Jul 18, 2024 03:08PM EST
Who is Peter Svennilson?
Peter Svennilson has an estimated net worth of $192 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., NGM BIOPHARMACEUTICALS INC, CONSTELLATION PHARMACEUTICALS INC, Revolution Medicines, Inc., Gritstone Oncology, Inc., RAPT Therapeutics, Inc., Nurix Therapeutics, Inc., Arcus Biosciences, Inc., Oric Pharmaceuticals, Inc., and eFFECTOR Therapeutics, Inc..
SEC CIK
Peter Svennilson's CIK is 0001606074
Past Insider Trading and Trends
2019 was Peter Svennilson's most active year for acquiring shares with 62 total transactions. Peter Svennilson's most active month to acquire stocks was the month of April. 2021 was Peter Svennilson's most active year for disposing of shares, totalling 77 transactions. Peter Svennilson's most active month to dispose stocks was the month of August. 2019 saw Peter Svennilson paying a total of $62,545,985.21 for 24,184,357 shares, this is the most they've acquired in one year. In 2020 Peter Svennilson cashed out on 23,617,898 shares for a total of $104,799,656.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNE DESIGN CORP. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.64M |
$5.85 | -$38,861,210.70 |
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
∞
| 2.68M |
$4.10 | $10,992,100.00 | 2.68M |
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
∞
| 800K |
$6.25 | $5,000,000.00 | 800K |
Sep 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
∞
| 3.16M |
$12.00 |
—
| 3.16M |
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NGM BIOPHARMACEUTICALS INC (NGM) Snapshot price: $1.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -21.74M |
—
|
—
| 1K |
Apr 5
| |||
Form 4
| +2.44% | 22.63K |
$0.69 | $15,506.86 | 949.86K |
Nov 15 - Nov 16
| |||
Form 4
| +24.80% | 184.27K |
$5.00 | $921,109.56 | 927.23K |
Jan 30 - Jan 31
| |||
Form 4
| +1.35% | 9.9K |
$5.00 | $49,494.06 | 742.96K |
Jan 23
| |||
Form 4
| +5.49% | 38.14K |
$5.00 | $190,602.67 | 733.06K |
Jan 19 - Jan 20
| |||
Form 4
| +0.78% | 5.38K |
$4.95 | $26,602.81 | 694.92K |
Jan 12
| |||
Form 4
| +81.23% | 309.07K |
$4.79 | $1,479,358.93 | 689.54K |
Jan 10 - Jan 11
| |||
Form 4
| +0.08% | 300 |
$4.98 | $1,493.01 | 380.47K |
Dec 12
| |||
Form 4
| +11.87% | 40.33K |
$5.00 | $201,587.91 | 380.17K |
Nov 21 - Nov 22
| |||
Form 4
| +69.33% | 139.15K |
$4.92 | $684,426.74 | 339.85K |
Nov 3 - Nov 4
| |||
Form 4
| +62.09% | 76.88K |
$4.86 | $373,637.60 | 200.7K |
Oct 27
| |||
Form 4
|
∞
| 123.82K |
$4.81 | $595,428.06 | 123.82K |
Oct 25 - Oct 26
| |||
Form 4
| +56.03% | 984.16K |
$13.50 | $13,286,173.50 | 2.74M |
Jun 9
| |||
Form 4
| +1.99% | 34.2K |
$13.03 | $445,738.86 | 1.76M |
Jun 2
| |||
Form 4
| +4.81% | 153.81K |
$13.46 | $2,069,667.23 | 3.35M |
May 31 - Jun 1
| |||
Form 4
| +0.74% | 22.91K |
$13.47 | $309,035.22 | 3.13M |
May 26 - May 27
| |||
Form 4
| +2.05% | 61.12K |
$13.40 | $819,948.39 | 3.05M |
May 24 - May 25
| |||
Form 4
| +1.36% | 39.7K |
$13.37 | $530,454.27 | 2.95M |
May 19 - May 20
| |||
Form 4
| +5.67% | 151.7K |
$13.31 | $2,022,003.67 | 2.83M |
May 17 - May 18
| |||
Form 4
| +6.80% | 162.53K |
$12.90 | $427,891.15 | 2.55M |
May 13 - May 16
| |||
Form 4
| +3.97% | 166.35K |
$11.63 | $1,902,031.79 | 4.35M |
May 11 - May 12
| |||
Form 4
| +6.42% | 114.44K |
$11.08 | $1,252,982.42 | 1.9M |
May 9 - May 10
| |||
Form 4
| +339.88% | 849.7K |
—
|
—
| 1.1M |
Jan 24 - Jan 25
| |||
Form 4
| +3.64% | 64.09K |
$17.65 | $1,131,357.81 | 1.83M |
Sep 1 - Sep 2
| |||
Form 4
| +3.68% | 62.49K |
$17.83 | $1,114,381.76 | 1.76M |
Aug 27 - Aug 28
| |||
Form 4
| +1.10% | 18.45K |
$17.96 | $331,349.41 | 1.7M |
Aug 21 - Aug 25
| |||
Form 4
| +3.98% | 64.31K |
$17.65 | $1,135,362.37 | 1.68M |
Aug 13 - Aug 17
| |||
Form 4
| +0.05% | 732 |
$17.99 | $13,168.68 | 1.62M |
Jul 30
| |||
Form 4
| +0.25% | 4.11K |
$17.99 | $73,848.95 | 1.62M |
Jul 28
| |||
Form 4
| +4.71% | 72.58K |
$17.93 | $1,301,643.23 | 1.61M |
Jul 24 - Jul 27
| |||
Form 4
| +1.55% | 24.19K |
$15.68 | $323,874.00 | 1.58M |
May 15 - Jul 22
| |||
Form 4
| +0.64% | 112.6K |
$14.95 | $1,683,399.90 | 17.71M |
Apr 8
| |||
Form 4
| +0.79% | 138.31K |
$14.17 | $1,960,233.31 | 17.59M |
Apr 3 - Apr 7
| |||
Form 4
| +1.46% | 250.98K |
$12.40 | $3,111,020.93 | 17.46M |
Mar 31 - Apr 2
| |||
Form 4
| +1.78% | 301.18K |
$11.89 | $3,580,543.59 | 17.21M |
Mar 23 - Mar 25
| |||
Form 4
| +1.75% | 291.55K |
$11.68 | $3,404,772.90 | 16.9M |
Mar 19 - Mar 20
| |||
Form 4
| +0.05% | 8.31K |
$18.00 | $149,526.00 | 16.61M |
Mar 5
| |||
Form 4
| +0.38% | 62.87K |
$17.97 | $1,129,424.58 | 16.6M |
Mar 2 - Mar 4
| |||
Form 4
| +0.46% | 75.45K |
$17.91 | $1,351,593.36 | 16.54M |
Feb 26 - Feb 28
| |||
Form 4
| +0.27% | 44.9K |
$15.96 | $716,604.00 | 16.47M |
Feb 6
| |||
Form 4
| +0.00% | 15 |
$12.00 | $180.00 | 16.42M |
Nov 11
| |||
Form 4
| +0.05% | 8.41K |
$11.99 | $100,823.91 | 16.42M |
Nov 4
| |||
Form 4
| +0.03% | 4.39K |
$11.93 | $52,351.82 | 16.41M |
Oct 22 - Oct 23
| |||
Form 4
| +0.52% | 84.94K |
$11.57 | $982,603.25 | 16.41M |
Oct 17 - Oct 21
| |||
Form 4
| +0.64% | 103K |
$10.31 | $1,061,930.00 | 16.32M |
Oct 14 - Oct 16
| |||
Form 4
| +0.33% | 53.17K |
$10.44 | $555,292.92 | 16.22M |
Oct 9 - Oct 11
| |||
Form 4
| +1.41% | 224.66K |
$14.00 | $3,145,294.24 | 16.17M |
Aug 7 - Aug 9
| |||
Form 4
| +0.04% | 6.13K |
$13.98 | $85,727.32 | 15.94M |
Aug 5 - Aug 6
| |||
Form 4
| +0.03% | 4.38K |
$13.98 | $61,244.20 | 15.94M |
Aug 1 - Aug 2
| |||
Form 4
| +0.18% | 28.06K |
$13.68 | $383,921.73 | 15.93M |
Jul 29 - Jul 30
| |||
Form 4
| +0.57% | 89.87K |
$13.49 | $1,212,429.87 | 15.9M |
Jul 24 - Jul 26
| |||
Form 4
| +0.43% | 67.74K |
$13.49 | $913,914.53 | 15.81M |
Jul 19 - Jul 23
| |||
Form 4
| +0.13% | 20.09K |
$13.72 | $275,602.52 | 15.75M |
Jul 15 - Jul 16
| |||
Form 4
| +0.20% | 31.88K |
$13.88 | $442,516.36 | 15.73M |
Jul 11 - Jul 12
| |||
Form 4
| +0.08% | 12.24K |
$13.78 | $168,650.06 | 15.69M |
Jun 24
| |||
Form 4
| +0.22% | 34.38K |
$13.90 | $477,848.63 | 15.68M |
Jun 19 - Jun 21
| |||
Form 4
| +0.19% | 29.76K |
$14.05 | $418,183.74 | 15.65M |
Jun 12 - Jun 14
| |||
Form 4
| +0.15% | 23.5K |
$13.74 | $322,894.05 | 15.62M |
Jun 7 - Jun 11
| |||
Form 4
| +0.16% | 25.2K |
$13.40 | $337,648.50 | 15.59M |
Jun 4 - Jun 6
| |||
Form 4
| +0.32% | 50K |
$13.50 | $675,000.00 | 15.57M |
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
| +0.12% | 17.92K |
$13.85 | $248,233.55 | 15.52M |
May 10
| |||
Form 4
| +0.37% | 57K |
$14.10 | $803,700.00 | 15.5M |
May 7
| |||
Form 4
| +530.19% | 14.99M |
$16.00 | $30,320,000.00 | 17.82M |
Apr 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONSTELLATION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.16% | -10.00K |
$36.95 | -$369,503.00 | 99.16K |
Feb 17
| |||
Form 4
| +1.18% | 30.11K |
$1.55 | $46,665.85 | 2.58M |
Dec 14
| |||
Form 4
| +0.69% | 41.67K |
$22.48 | $936,929.15 | 6.05M |
Mar 19 - Mar 20
| |||
Form 4
| +29.68% | 1.41M |
$8.50 | $11,999,994.00 | 6.17M |
Oct 3
| |||
Form 4
| +42,230.46% | 4.67M |
—
|
—
| 4.68M |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Revolution Medicines, Inc. (RVMD) Snapshot price: $30.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.75% | -76.41K |
$42.67 | -$3,269,345.21 | 10.07M |
Scheduled
|
Apr 26 - Apr 28
| ||
Form 4
| -1.02% | -70.93K |
$44.32 | -$3,153,745.02 | 6.87M |
Scheduled
|
Apr 8 - Apr 9
| ||
Form 4
| -0.80% | -85.67K |
$46.77 | -$4,023,040.87 | 10.58M |
Scheduled
|
Apr 5 - Apr 7
| ||
Form 4
| -21.41% | -986.89K |
—
|
—
| 3.62M |
Dec 9
| |||
Form 4
| -30.68% | -2.03M |
$36.40 | -$73,788,478.40 | 4.58M |
Nov 16
| |||
Form 4
|
∞
| 7.23K |
—
|
—
| 7.23K |
Jun 17
| |||
Form 4
|
∞
| 7.98M |
—
|
—
| 7.98M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Gritstone Oncology, Inc. (GRTS) Snapshot price: $2.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
∞
| 3.1M |
—
|
—
| 3.1M |
Oct 2
| |||
Form 4
|
∞
| 3.1M |
—
|
—
| 3.1M |
Oct 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||